Acknowledgements
We would like to thank the Center for Clinical Studies Tübingen, especially Dr. Beatrix Welte, the Institute for Clinical Epidemiology and Applied Statistics (IKEAB), and sync2brain GmbH for their support in the trial. We also thank Deutsche Stiftung Schlaganfallhilfe e.V. and the self-help group “Reiten mit Handicap” for patient representation within this trial.